Viewing Study NCT06550518

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 5:05 AM
Ignite Modification Date: 2026-02-02 @ 7:06 PM
Study NCT ID: NCT06550518
Status: COMPLETED
Last Update Posted: 2024-08-13
First Post: 2021-06-18
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Real-life Second-line Epirubicin-Paclitaxel Regimen as Treatment of Relapsed Small-Cell Lung Cancer : EpiTax Study.
Sponsor: University Hospital, Brest
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Small Cell Lung Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Small-cell Lung Cancer View
None Epirubicin View
None Paclitaxel View
None Cerebral Efficacy View
None Real-life View